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infected bynon-ESBL-producing isolates gave negative resultswith
the ESBL NDP test. Results of the ESBL NDP test were 100% corre-
latedwith those of the double disk-diffusionmethodwith themain
advantage that theywere obtained in less than30mindirectly from
the clinical sample versus an additive 24h time of incubation for
the double disk-diffusion method.
Conclusion: Using the ESBL NDP test, identiﬁcation of an ESBL
producer responsible for a bacteremia can be reduced from 24-
48hours to 30min with 100% sensibility, 100% speciﬁcity, 100%
negative predictive value and 100% positive predictive value. Since
the successful treatment of septicemia depends on prompt admin-
istration of the appropriate antimicrobial agents, use of the ESBL
NDP test directly from positive blood cultures may signiﬁcantly
improve the outcome of infected patients.
http://dx.doi.org/10.1016/j.ijid.2014.03.1174
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A case of chronic meningitis caused by
Cryptococcus neoformans, which was detected
only with the use of mycobacterial blood
culture bottle for cerebrospinal ﬂuid
H. Matsuo, K. Iwata
Kobe University, Kobe, Hyogo, Japan
Background: Cryptococcus is known to cause chronic meningi-
tis. Diagnosis is usually made with the use of cryptococcus antigen
test of cerebrospinal ﬂuid (CSF). Despite its high sensitivity, false
negative result can occur, particularly then the amount of the
organism in CSF was small. We herein report a case of cryptococcal
meningitis in a non-HIV patient, with negative india ink, negative
CSF cryptococcal antigen test, negative routine CSF fungal culture,
andpositiveonlywith theuseofmycobacterial bloodculturebottle.
Methods & Materials: The patient is 38-year-old man without
signiﬁcant pastmedical history,whopresentedwith gait instability
for 40 days. He also complained of intermittent headache since 20
days prior to the ﬁrst visit, which worsened gradually. He started
to feel weak on his left lower extremity, and had difﬁculty in stand-
ings up. On physical examination, he was alert but disoriented. His
neck was supple, but had gait instability. Head magnetic resonance
imaging study only showed widening of lateral ventricles. Cere-
brospinal ﬂuid examination revealed opening pressure was 24.5
cmH2O, cell count 143/L with 87% polymorphonuclear cells, pro-
tein 184mg/dL, glucose 7mg/dL, with negative Gram staining, acid
fastbacilli staining, india ink staining, andcryptococcal antigen test.
Results: Cryptococcus neoformans var grubii was detected only
from mycobacterial culture bottle 7 days later, despite negative
routine fungal culture. He was treated with amphotericin B lipid
complex and ﬂucytosine, together with spinal drainage, followed
by ﬂuconazolemaintenance therapy for 6months. His neurological
abnormalities improved without recurrence
Conclusion:Cryptococcal antigen test ofCSFhashigh sensitivity
for the diagnosis of meningitis, but false negative still can occur.
Previous studies suggest that theuseofmycobacterial bloodculture
bottle may increase the sensitivity of fungemia in general. There is
no literature reporting theuseofmycobacterial bloodculturebottle
for the diagnosis of cryptococcal meningitis. The use of it on CSF,
on top of conventional work up, may heighten the diagnostic yield
of this infection.
http://dx.doi.org/10.1016/j.ijid.2014.03.1175
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Background: Failure to demonstrate the presence of malaria
parasites prior to treatment with anti-malarial drugs remains a
challenge in Uganda, often resulting into over-prescription of anti-
malarial drugs to febrile patients suspected of malaria. The aim of
this studywas to describe the role of utilization ofmalaria diagnos-
tic tests and associated factors in the receipt of anti-malarial drugs
among febrile patients suspected of malaria.
Methods & Materials: In a cross-sectional study design, client-
exit interviews with febrile patients and key-informant interviews
withpurposively selectedhealthworkerswere conducted at health
center IVs in Mukono district. Data entry and analysis were done
using Epi-Data 3.2 and STATA 10 respectively. Data were described
using frequency distributions andproportions. Chi squarewas used
in two by two tables, odds ratios as the measure of association and
an alpha level of 0.05 was used in all signiﬁcance tests.
Results: Out of 408 respondents, 359 (88%) utilized malaria
diagnostic tests and 241(59%) received antimalarial drugs. Major-
ity were female 252 (61.8%) and a third of the sample was aged ﬁve
years and below. There were no statistically signiﬁcant differences
between utilizers and non-utilizers in most characteristics except
age, history of indoor residual spraying and satisfaction with ser-
vices. Utilizers were 75% less likely to receive anti-malarial drugs
than non-utilizers after controlling for age, sex and residence (OR:
0.25, 95%CI: 0.09, 0.66).
Power was the main limitation to microscopic diagnosis of
malaria and laboratory personnel had limited knowledge on
malaria treatment guidelines.
Conclusion: Utilizers were 75% less likely to receive anti-
malarial drugs as opposed to non-utilizers. This implies that
increasing utilization of malaria diagnostic tests can reduce the
problem of overprescription of anti-malarial drugs by 75% among
those tested formalaria, sinceantimalarial drugswill be receivedby
only those with a parasitologically-conﬁrmed diagnosis of malaria.
http://dx.doi.org/10.1016/j.ijid.2014.03.1176
